Search results for "Heart failure"
Early beta-blocker use may reduce 30-day mortality in patients with acute MI
Patients receiving early beta-blockers had a 30-day mortality rate of 2.3%, compared with 8.6% in those who did not, the study found.
https://immattersacp.org/weekly/archives/2016/09/27/4.htm
27 Sep 2016
Diagnosis at 10 paces for bitemporal wasting
In a new series, Pearls from I.M. Peers, Paul Dallas, MD, MACP, explains how making a simple observation in a patient could indicate a serious diagnosis.
https://immattersacp.org/archives/2022/01/diagnosis-at-10-paces-for-bitemporal-wasting.htm
1 Jan 2022
Digoxin may be linked to increased mortality risk
Digoxin may be associated with increased mortality risk, especially in patients with atrial fibrillation, according to a systematic review and meta-analysis.
https://immattersacp.org/weekly/archives/2015/05/12/5.htm
12 May 2015
AHA evaluates heart failure risks from prescription drugs, OTCs, alternative products
The scientific statement identifies prescription medications that may exacerbate underlying myocardial dysfunction, prescription drugs known to cause direct myocardial toxicity, and the sodium level of some over-the-counter medications, among other concerns.
https://immattersacp.org/weekly/archives/2016/07/19/5.htm
19 Jul 2016
How to handle uncertainty
Studies have yet to tease out how physicians' tolerance of uncertainty affects their behavior and decision making, and even their sense of burnout.
https://immattersacp.org/archives/2023/02/how-to-handle-uncertainty.htm
1 Feb 2023
Guideline updated to include new drugs for stage C heart failure with reduced ejection fraction
Among other recommendations, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, or an angiotensin receptor-neprilysin inhibitor, along with a beta-blocker and an aldosterone antagonist, is the new recommended therapy to reduce morbidity and mortality in patients with chronic symptomatic heart failure with reduced ejection fraction.
https://immattersacp.org/weekly/archives/2016/05/24/2.htm
24 May 2016
A living guideline for depression treatment
ACP recommends choosing between a second-generation antidepressant or cognitive behavioral therapy for adults in the acute phase of moderate to severe major depressive disorder.
https://immattersacp.org/archives/2023/06/a-living-guideline-for-depression-treatment.htm
1 Jun 2023
Beta-blockers not associated with lower risk of death after acute MI in patients without heart failure, study finds
The insignificant effect of beta-blockers on survival was also apparent at one month and six months after discharge, as well as in separate analyses of patients with STEMI and NSTEMI.
https://immattersacp.org/weekly/archives/2017/06/06/5.htm
6 Jun 2017
Ischemic heart disease linked to worse prognosis in heart failure patients with type 2 diabetes
Type 2 diabetes was associated with greater risk for all-cause mortality in patients with ischemic and nonischemic heart failure, previous revascularization was associated with better survival, and most patients with type 2 diabetes and nonischemic heart failure had at least 1 treatable comorbid condition associated with heart failure risk.
https://immattersacp.org/weekly/archives/2016/09/20/4.htm
20 Sep 2016
Sacubitril-valsartan appears cost-effective in certain heart failure patients
Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://immattersacp.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016